- Sustained release coatings, essential for controlled drug delivery, play a critical role in enhancing the therapeutic performance of oral solid dosage forms by ensuring prolonged drug release, reducing dosing frequency, and improving patient compliance across various chronic treatment regimens.
- The growing prevalence of chronic diseases, expanding geriatric population, and heightened emphasis on personalized medicine are driving increased adoption of sustained release coating technologies in the pharmaceutical industry, highlighting the importance of formulation efficiency, precision release control, and regulatory compliance.
- North America dominates the Sustained Release Coating Market with the largest revenue share of 38.01% in 2024, supported by a strong pharmaceutical manufacturing base, extensive R&D activities, and the presence of leading players focused on developing advanced drug delivery systems. The U.S. leads the region, driven by FDA approvals, patent activity, and demand for modified-release therapeutics
- Asia-Pacific is expected to be the fastest-growing region in the Sustained Release Coating Market during the forecast period, propelled by increasing healthcare expenditures, expanding generic drug production, and the rise of contract manufacturing organizations (CMOs) in countries such as India, China, and South Korea
- Polymeric coating materials dominate the Sustained Release Coating Market with a market share of 40.3% in 2024, attributed to their versatility, biocompatibility, and effectiveness in tailoring drug release kinetics, especially in complex and multi-layered tablet formulations used in high-volume pharmaceutical applications
